The definite role of myeloperoxidase activation in oxidative damage and ischemic stroke was confirmed by Forghani et al. [171] and Kim et al. [172] who studied the effect of myeloperoxidase inhibitor on infarct size and volume in rodent ischemic stroke models. The gene discussed is MPO; the disease is ischemic stroke.